Cargando…

Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach

Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Wolfgang, Moskalev, Igor, Janssen, Claudia, Hayashi, Tetsutaro, Awrey, Shannon, Gust, Kilian M., So, Alan I., Zhang, Kaixin, Fazli, Ladan, Li, Estelle, Thüroff, Joachim W., Lange, Dirk, Black, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608695/
https://www.ncbi.nlm.nih.gov/pubmed/23555699
http://dx.doi.org/10.1371/journal.pone.0059536
_version_ 1782264270646411264
author Jäger, Wolfgang
Moskalev, Igor
Janssen, Claudia
Hayashi, Tetsutaro
Awrey, Shannon
Gust, Kilian M.
So, Alan I.
Zhang, Kaixin
Fazli, Ladan
Li, Estelle
Thüroff, Joachim W.
Lange, Dirk
Black, Peter C.
author_facet Jäger, Wolfgang
Moskalev, Igor
Janssen, Claudia
Hayashi, Tetsutaro
Awrey, Shannon
Gust, Kilian M.
So, Alan I.
Zhang, Kaixin
Fazli, Ladan
Li, Estelle
Thüroff, Joachim W.
Lange, Dirk
Black, Peter C.
author_sort Jäger, Wolfgang
collection PubMed
description Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected between the muscle wall and the mucosa to separate these layers, and tumor cells were subsequently injected into this space. Bioluminescence and ultrasound were used to monitor tumor growth. Contrast-enhanced ultrasound was used to study changes in tumor perfusion after systemic gemcitabine/cisplatin treatment. To demonstrate proof of principle that therapeutic agents can be injected into established xenografts under ultrasound guidance, oncolytic virus (VSV) was injected into UM-UC3 tumors. Xenograft tissue was harvested for immunohistochemistry after 23–37 days. Percutaneous injection of tumor cells into the bladder wall was performed efficiently (mean time: 5.7 min) and without complications in all 50 animals. Ultrasound and bioluminescence confirmed presence of tumor in the anterior bladder wall in all animals 3 days later. The average tumor volumes increased steadily over the study period. UM-UC13 tumors showed a marked decrease in volume and perfusion after chemotherapy. Immunohistochemical staining for VSV-G demonstrated virus uptake in all UM-UC3 tumors after intratumoral injection. We have developed a novel method for creating orthotopic bladder cancer xenograft in a minimally invasive fashion. In our hands this has replaced the traditional model requiring laparotomy, because this model is more time efficient, more precise and associated with less morbidity for the mice.
format Online
Article
Text
id pubmed-3608695
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36086952013-04-03 Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach Jäger, Wolfgang Moskalev, Igor Janssen, Claudia Hayashi, Tetsutaro Awrey, Shannon Gust, Kilian M. So, Alan I. Zhang, Kaixin Fazli, Ladan Li, Estelle Thüroff, Joachim W. Lange, Dirk Black, Peter C. PLoS One Research Article Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected between the muscle wall and the mucosa to separate these layers, and tumor cells were subsequently injected into this space. Bioluminescence and ultrasound were used to monitor tumor growth. Contrast-enhanced ultrasound was used to study changes in tumor perfusion after systemic gemcitabine/cisplatin treatment. To demonstrate proof of principle that therapeutic agents can be injected into established xenografts under ultrasound guidance, oncolytic virus (VSV) was injected into UM-UC3 tumors. Xenograft tissue was harvested for immunohistochemistry after 23–37 days. Percutaneous injection of tumor cells into the bladder wall was performed efficiently (mean time: 5.7 min) and without complications in all 50 animals. Ultrasound and bioluminescence confirmed presence of tumor in the anterior bladder wall in all animals 3 days later. The average tumor volumes increased steadily over the study period. UM-UC13 tumors showed a marked decrease in volume and perfusion after chemotherapy. Immunohistochemical staining for VSV-G demonstrated virus uptake in all UM-UC3 tumors after intratumoral injection. We have developed a novel method for creating orthotopic bladder cancer xenograft in a minimally invasive fashion. In our hands this has replaced the traditional model requiring laparotomy, because this model is more time efficient, more precise and associated with less morbidity for the mice. Public Library of Science 2013-03-26 /pmc/articles/PMC3608695/ /pubmed/23555699 http://dx.doi.org/10.1371/journal.pone.0059536 Text en © 2013 Jäger et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jäger, Wolfgang
Moskalev, Igor
Janssen, Claudia
Hayashi, Tetsutaro
Awrey, Shannon
Gust, Kilian M.
So, Alan I.
Zhang, Kaixin
Fazli, Ladan
Li, Estelle
Thüroff, Joachim W.
Lange, Dirk
Black, Peter C.
Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title_full Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title_fullStr Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title_full_unstemmed Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title_short Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
title_sort ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608695/
https://www.ncbi.nlm.nih.gov/pubmed/23555699
http://dx.doi.org/10.1371/journal.pone.0059536
work_keys_str_mv AT jagerwolfgang ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT moskalevigor ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT janssenclaudia ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT hayashitetsutaro ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT awreyshannon ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT gustkilianm ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT soalani ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT zhangkaixin ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT fazliladan ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT liestelle ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT thuroffjoachimw ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT langedirk ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach
AT blackpeterc ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach